104668-15-7Relevant articles and documents
TIPP: A Highly Potent and Stable Pseudopeptide δ Opioid Receptor Antagonist with Extraordinary δ Selectivity
Schiller, Peter W.,Weltrowska, Grazyna,Nguyen, Thi M.-D.,Wilkes, Brian C.,Chung, Nga N.,Lemieux, Carole
, p. 3182 - 3187 (1993)
Pseudopeptide analogues of the δ opioid antagonists H-Tyr-Tic-Phe-Phe-OH (TIPP) and H-Tyr-Tic-Phe-OH (TIP) containing a reduced peptide bond between the Tic2 and Phe3 residues were synthesized.The two compounds, H-Tyr-TicψPhe-
Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1
Lu, Jian,Bart, Aaron G.,Wu, Qian,Criscione, Kevin R.,McLeish, Michael J.,Scott, Emily E.,Grunewald, Gary L.
, p. 13878 - 13898 (2020/12/02)
The enzyme phenylethanolamine N-methyltransferase (PNMT, EC 2.1.1.28) catalyzes the final step in the biosynthesis of epinephrine and is a potential drug target, primarily for the control of hypertension. Unfortunately, many potent PNMT inhibitors also po
Piperazine- and piperidine-derivatives as melanocortin receptor agonists
-
Page/Page column 58, (2010/02/06)
The present invention relates to melanocortin receptor agonists of formula I, which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction.